Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
D107320-10mg | 10mg | In stock | $19.90 | |
D107320-20mg | 20mg | In stock | $24.90 | |
D107320-50mg | 50mg | In stock | $36.90 | |
D107320-100mg | 100mg | In stock | $53.90 | |
D107320-250mg | 250mg | In stock | $89.90 | |
D107320-500mg | 500mg | In stock | $129.90 | |
D107320-1g | 1g | In stock | $187.90 | |
D107320-5g | 5g | In stock | $657.90 |
Potent cytotoxic agent
Synonyms | Docetaxel [INN] | D07866 | NSC 759850 | CS-0214895 | Lead di(acetate) | NCGC00242509-01 | DOCETAXEL MYLAN | Ethanol, 2,2'-iminodi-, 3,5-diiodo-4-oxo-1(4H)-pyridineacetate (salt) | KS-1452 | NCGC00181306-01 | DB12492 | Docetaxel anhydrous | Docetaxol | EmD |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Docetaxel is a taxane anti-cancer agent related to paclitaxel. It binds to and stabilizes the β?tubulin subunit of microtubules, preventing depolymerization of the mitotic spindle thus leading to cell cycle arrest and apoptosis.Potent cytotoxic agent in v |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of tubulin beta class I |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Docetaxel(Taxotere), an analog of taxol, is an inhibitor of depolymerisation of microtubules through binding to stabilized microtubules. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate |
---|---|
INCHI | InChI=1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1 |
InChi Key | ZDZOTLJHXYCWBA-VCVYQWHSSA-N |
Canonical SMILES | CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O |
Isomeric SMILES | CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O |
WGK Germany | 3 |
RTECS | DA4172750 |
PubChem CID | 148124 |
Molecular Weight | 807.88 |
DrugBank Ligand | DB01248 |
---|---|
PubChem CID | 148124 |
CAS Registry No. | 114977-28-5 |
ChEMBL Ligand | CHEMBL92 |
ChEBI | CHEBI:4672 |
Wikipedia | Docetaxel |
RCSB PDB Ligand | TXL |
PEP | docetaxel |
DrugCentral Ligand | 939 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H2409335 | Certificate of Analysis | Aug 19, 2024 | D107320 |
H2409336 | Certificate of Analysis | Aug 19, 2024 | D107320 |
K2111810 | Certificate of Analysis | Jan 04, 2024 | D107320 |
C2205397 | Certificate of Analysis | Dec 11, 2023 | D107320 |
C2205403 | Certificate of Analysis | Dec 11, 2023 | D107320 |
C2205575 | Certificate of Analysis | Dec 11, 2023 | D107320 |
F1828013 | Certificate of Analysis | Nov 07, 2023 | D107320 |
I2306404 | Certificate of Analysis | Sep 16, 2023 | D107320 |
I2306402 | Certificate of Analysis | Sep 16, 2023 | D107320 |
I2306352 | Certificate of Analysis | Sep 16, 2023 | D107320 |
I2304603 | Certificate of Analysis | Sep 16, 2023 | D107320 |
I2306355 | Certificate of Analysis | Sep 11, 2023 | D107320 |
I2306354 | Certificate of Analysis | Sep 11, 2023 | D107320 |
I2306353 | Certificate of Analysis | Sep 11, 2023 | D107320 |
I2306356 | Certificate of Analysis | Sep 11, 2023 | D107320 |
I2306357 | Certificate of Analysis | Sep 11, 2023 | D107320 |
I2306381 | Certificate of Analysis | Sep 11, 2023 | D107320 |
I2306382 | Certificate of Analysis | Sep 11, 2023 | D107320 |
I1924081 | Certificate of Analysis | Apr 11, 2023 | D107320 |
B2306919 | Certificate of Analysis | Feb 11, 2023 | D107320 |
D2122188 | Certificate of Analysis | Jan 17, 2023 | D107320 |
I2219402 | Certificate of Analysis | Sep 22, 2022 | D107320 |
G2227730 | Certificate of Analysis | Jul 30, 2022 | D107320 |
K1820062 | Certificate of Analysis | Jul 11, 2022 | D107320 |
K1820061 | Certificate of Analysis | Jul 11, 2022 | D107320 |
D2313829 | Certificate of Analysis | Mar 11, 2022 | D107320 |
C2205404 | Certificate of Analysis | Mar 11, 2022 | D107320 |
C2205402 | Certificate of Analysis | Mar 11, 2022 | D107320 |
B2306918 | Certificate of Analysis | Mar 11, 2022 | D107320 |
Melt Point(°C) | 186-191°C |
---|
Pictogram(s) | GHS08, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H319:Causes serious eye irritation H341:Suspected of causing genetic defects H351:Suspected of causing cancer H372:Causes damage to organs through prolonged or repeated exposure H360:May damage fertility or the unborn child H361:Suspected of damaging fertility or the unborn child H362:May cause harm to breast-fed children |
Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P260:Do not breathe dust/fume/gas/mist/vapors/spray. P281:Use personal protective equipment as required. P270:Do not eat, drink or smoke when using this product. P263:Avoid contact during pregnancy/while nursing. P203:Obtain, read and follow all safety instructions before use. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P318:if exposed or concerned, get medical advice. P337+P317:If eye irritation persists: Get medical help. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
RTECS | DA4172750 |
1. Wei Pei, Yuqing Li, Yixian Wu, Yuan Wu, Ling Cai, Shaozhuo Wang, Shoulin Wang, Jin Chen. (2023) A Tumoricidal Lipoprotein Complex Electrostatically Stabilized on Mesoporous Silica as Nanotherapeutics and Nanoadjuvant for Potentiating Immunotherapy of Triple Negative Breast Cancer. ADVANCED FUNCTIONAL MATERIALS, (2308117). [PMID:19463981] [10.1002/adfm.202308117] |
2. Shuncheng Yao, Shaobo Wang, Minjia Zheng, Zhuo Wang, Zhirong Liu, Zhong Lin Wang, Linlin Li. (2023) Implantable, Biodegradable, and Wireless Triboelectric Devices for Cancer Therapy Through Disrupting Microtubule and Actins Dynamics. ADVANCED MATERIALS, (2303962). [PMID:37392034] [10.1002/adma.202303962] |
3. Zhuang Yu, Wang Yuxiao, Li Ning, Meng Haitao, Li Zhiyu, Luo Jianguang, Qiu Zhixia. (2023) Hydrolytic Metabolism of Withangulatin A Mediated by Serum Albumin Instead of Common Esterases in Plasma. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 48 (4): (363-376). [PMID:37344636] [10.1007/s13318-023-00834-8] |
4. Jiawei Li, Chunmei Fan, Zhongyang Lv, Ziying Sun, Jie Han, Maochun Wang, Huiming Jiang, Kuoyang Sun, Guihua Tan, Hu Guo, Anlong Liu, Heng Sun, Xingquan Xu, Rui Wu, Wenjin Yan, Qing Jiang, Shiro Ikegawa, Xiao Chen, Dongquan Shi. (2023) Microtubule stabilization targeting regenerative chondrocyte cluster for cartilage regeneration. Theranostics, 13 (10): ( 3480–3496). [PMID:37351173] [10.7150/thno.85077] |
5. Rengui Xu, Honglian Guo, Xiuli Chen, Jiarong Xu, Yusheng Gong, Peng Cao, Chunyu Wei, Fei Xiao, Di Wu, Wei Chen, Lin Wang, Zheng Wang. (2023) Smart hydrothermally responsive microneedle for topical tumor treatment. JOURNAL OF CONTROLLED RELEASE, 358 (566). [PMID:37182803] [10.1016/j.jconrel.2023.05.008] |
6. Qinhui Ren, Yufu Ma, Fuhua Wei, Lan Qin, Hongliang Chen, Zhao Liang, Siyuan Wang. (2023) Preparation of Zr-MOFs for the adsorption of doxycycline hydrochloride from wastewater. Green Processing and Synthesis, 12 (1): [PMID:] [10.1515/gps-2022-8127] |
7. Tan Hu, Yang Xu, Gang Xu. (2023) Dipeptide-polysaccharides hydrogels through co-assembly. FOOD CHEMISTRY, 422 (136272). [PMID:37141751] [10.1016/j.foodchem.2023.136272] |
8. Fang Fang, Shaohua Zhang, Chaofan Chen, Xueying Wang, Chuannan Luo, Qin Wei. (2023) A fluorescent nanoprobe based on N/S co-doped carbon dots coupled with molecularly imprinted polymers for the detection of curcumin. OPTICAL MATERIALS, 139 (113800). [PMID:] [10.1016/j.optmat.2023.113800] |
9. Zhen Yu, Xundou Li, Jinhong Duan, Xian-Da Yang. (2023) Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel. International Journal of Nanomedicine, [PMID:32982230] [10.2147/IJN.S267177] |
10. Tong Le, Zhou ZeYang, Wang Gang, Wu Chao. (2023) A self-microemulsion enhances oral absorption of docetaxel by inhibiting P-glycoprotein and CYP metabolism. Drug Delivery and Translational Research, 13 (4): (983-993). [PMID:36515864] [10.1007/s13346-022-01255-x] |
11. Li Huang, Huaqiang Fang, Teng Zhang, Binbin Hu, Shichen Liu, Fanzhen Lv, Zhaoxia Zeng, Huijie Liu, Weimin Zhou, Xiaolei Wang. (2023) Drug-loaded balloon with built-in NIR controlled tip-separable microneedles for long-effective arteriosclerosis treatment. Bioactive Materials, 23 (526). [PMID:36514389] [10.1016/j.bioactmat.2022.11.015] |
12. Ruifeng Wu, Zhiqiang Zhang, Baohua Wang, Ge Chen, Yaozhong Zhang, Haowen Deng, Zilong Tang, Junjie Mao, Lei Wang. (2022) Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles. Drug Design Development and Therapy, [PMID:32606595] [10.2147/DDDT.S246574] |
13. Dongsheng Fu, Jinhui You, Ruijie Guo, Jie Zhang, Qiang Li, Jing Wen, Huifang Wang, Hong Yan. (2022) Preparation of Nanostructured Graphene Oxide and Its Application in Drug Loading and Sustained Release. ChemistrySelect, 7 (30): (e202200670). [PMID:] [10.1002/slct.202200670] |
14. Hongming Liu, Qin Zhou, Yongfu Lian. (2022) Polymethyl(1–Butyric acidyl)silane–Assisted Dispersion and Density Gradient Ultracentrifugation Separation of Single–Walled Carbon Nanotubes. Nanomaterials, 12 (12): (2094). [PMID:35745430] [10.3390/nano12122094] |
15. Lingling Xu, Chuan Zhou, Fan Wang, Huiqin Liu, Guangyuan Dong, Siyi Zhang, Tao Liu. (2022) Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells. RSC Advances, 12 (28): (18004-18011). [PMID:35765336] [10.1039/D2RA02301F] |
16. Wei Pei, Ling Cai, Xing Gong, Li Zhang, Jiarong Zhang, Ping Zhu, Huijun Jiang, Chao Wang, Shoulin Wang, Jin Chen. (2022) Drug-loaded oleic-acid grafted mesoporous silica nanoparticles conjugated with α-lactalbumin resembling BAMLET-like anticancer agent with improved biocompatibility and therapeutic efficacy. Materials Today Bio, 15 (100272). [PMID:35607417] [10.1016/j.mtbio.2022.100272] |
17. Yingying Zhang, Hongxia Duan, Heming Zhao, Lingling Qi, Yanhong Liu, Zheao Zhang, Chao Liu, Liqing Chen, Mingji Jin, Youyan Guan, Zhonggao Gao, Wei Huang. (2022) Development and Evaluation of a PSMA-Targeted Nanosystem Co-Packaging Docetaxel and Androgen Receptor siRNA for Castration-Resistant Prostate Cancer Treatment. Pharmaceutics, 14 (5): (964). [PMID:35631549] [10.3390/pharmaceutics14050964] |
18. Jia Gao, Li Chen, Yongsheng Yan, Jian Lu, Wendong Xing, Jiangdong Dai, Minjia Meng, Yilin Wu. (2021) Dot-matrix-initiated molecularly imprinted nanocomposite membranes for selective recognition: a high-efficiency separation system with an anti-oil fouling layer. Environmental Science-Nano, 8 (10): (2932-2949). [PMID:] [10.1039/D1EN00296A] |
19. Yingying Chai, Yuefei Wang, Bingqi Li, Wei Qi, Rongxin Su, Zhimin He. (2021) Microfluidic Synthesis of Lignin/Chitosan Nanoparticles for the pH-Responsive Delivery of Anticancer Drugs. LANGMUIR, 37 (23): (7219–7226). [PMID:34078082] [10.1021/acs.langmuir.1c00778] |
20. Ruiqi Xu, Mengnan Zeng, Yuanyuan Wu, Shengchao Wang, Beibei Zhang, Jingke Zhang, Yuxuan Kan, Benke Li, Bing Cao, Xiaoke Zheng, Weisheng Feng. (2021) Acetone Extract of Cornus officinalis Leaves Exerts Anti-Melanoma Effects via Inhibiting STAT3 Signaling. OncoTargets and Therapy, 14 ( 3487–3501). [PMID:34093025] [10.2147/OTT.S308371] |
21. Wenjia Wang, Xiaoqin Zhang, Zhiqian Li, Dayi Pan, Hongyan Zhu, Zhongwei Gu, Jie Chen, Hu Zhang, Qiyong Gong, Kui Luo. (2021) Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy. CARBOHYDRATE POLYMERS, 267 (118160). [PMID:34119134] [10.1016/j.carbpol.2021.118160] |
22. Zhirong Zhu, Guiliang Tang, Jiajun Yan. (2020) MicroRNA‑122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2. Experimental and Therapeutic Medicine, 20 (6): (1-1). [PMID:33178345] [10.3892/etm.2020.9377] |
23. Hongyan Zhang, Shuang Dong, Sheng Zhang, Yufen Li, Ji Li, Yinghui Dai, Dongkai Wang. (2021) pH-responsive lipid polymer hybrid nanoparticles (LPHNs) based on poly (β-amino ester) as a promising candidate to resist breast cancers. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 61 (102102). [PMID:] [10.1016/j.jddst.2020.102102] |
24. Yuan He, Zhuyifan Ye, Xinyang Liu, Zhengjie Wei, Fen Qiu, Hai-Feng Li, Ying Zheng, Defang Ouyang. (2020) Can machine learning predict drug nanocrystals?. JOURNAL OF CONTROLLED RELEASE, 322 (274). [PMID:32234511] [10.1016/j.jconrel.2020.03.043] |
25. Tian'e Chen, Liangxing Tu, Ge Wang, Na Qi, Wei Wu, Wei Zhang, Jianfang Feng. (2020) Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 578 (119105). [PMID:32018019] [10.1016/j.ijpharm.2020.119105] |
26. Yao Yang, Zhengwei Huang, Jinyuan Li, Ziran Mo, Ying Huang, Cheng Ma, Wenhao Wang, Xin Pan, Chuanbin Wu. (2019) PLGA Porous Microspheres Dry Powders for Codelivery of Afatinib-Loaded Solid Lipid Nanoparticles and Paclitaxel: Novel Therapy for EGFR Tyrosine Kinase Inhibitors Resistant Nonsmall Cell Lung Cancer. Advanced Healthcare Materials, 8 (23): (1900965). [PMID:31664795] [10.1002/adhm.201900965] |
27. Jiafeng Gao, Kai Fan, Yipeng Jin, Linna Zhao, Qian Wang, Yinian Tang, Huihao Xu, Zhongjie Liu, Shuaiyu Wang, Jiahao Lin, Degui Lin. (2019) PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 140 (105070). [PMID:31518679] [10.1016/j.ejps.2019.105070] |
28. Wei Fu, Zhiming Hong, Xujun You, Jing Din, Baishu Chen, Beibei Zhao, Gengyan Yuan, Qixin Li. (2019) Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer. BIOMEDICINE & PHARMACOTHERAPY, 118 (109374). [PMID:31545228] [10.1016/j.biopha.2019.109374] |
29. Tao Liu, Jingzhen Li, Xidong Wu, Siyi Zhang, Zhongming Lu, Guanxue Li, Junzheng Li, Shaohua Chen. (2019) Transferrin-targeting redox hyperbranched poly(amido amine)-functionalized graphene oxide for sensitized chemotherapy combined with gene therapy to nasopharyngeal carcinoma. DRUG DELIVERY, 26 (1): (744-755). [PMID:31340676] [10.1080/10717544.2019.1642421] |
30. Ting Zhao, Shiwei Qin, linna Peng, Pan Li, Tao Feng, Jingyuan Wan, Pei Yuan, Liangke Zhang. (2019) Novel hyaluronic acid-modified temperature-sensitive nanoparticles for synergistic chemo-photothermal therapy. CARBOHYDRATE POLYMERS, 214 (221). [PMID:30925992] [10.1016/j.carbpol.2019.03.043] |
31. Ruoning Wang, Mengmeng Yang, Guoyuan Li, Xin Wang, Zhenhai Zhang, Hongzhi Qiao, Jun Chen, Zhipeng Chen, Xiaobin Cui, Junsong Li. (2019) Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity. COLLOIDS AND SURFACES B-BIOINTERFACES, 174 (270). [PMID:30469048] [10.1016/j.colsurfb.2018.11.029] |
32. Lei Xu, Shuo Wu, Xiaoqiu Zhou. (2018) Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma. JOURNAL OF BIOMATERIALS APPLICATIONS, [PMID:29699442] [10.1177/0885328218772721] |
33. Ling-Yuan Guo, Shu-Zhen Yan, Qiang Li, Qiao Xu, Xi Lin, Shan-Shan Qi, Shu-Qin Yu, Shuang-Lin Chen. (2017) Poly(lactic-co-glycolic) acid nanoparticles improve oral bioavailability of hypocrellin A in rat. RSC Advances, 7 (67): (42073-42082). [PMID:] [10.1039/C7RA04748G] |
34. Lin Yu, Xiaofeng Wu, Min Chen, Huarong Huang, Yan He, Huaqian Wang, Dongli Li, Zhiyun Du, Kun Zhang, Susan Goodin, Xi Zheng. (2017) The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer. International Journal of Medical Sciences, 14 (4): ( 356–366). [PMID:28553168] [10.7150/ijms.18382] |
35. Enhui Zhang, Ronge Xing, Song Liu, Kecheng Li, Yukun Qin, Huahua Yu, Pengcheng Li. (2017) Comparison in docetaxel-loaded nanoparticles based on three different carboxymethyl chitosans. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 101 (1012). [PMID:28389400] [10.1016/j.ijbiomac.2017.03.195] |
36. Zejun Xu, Yi Zhang, Qian Hu, Qiao Tang, Jiake Xu, Jianping Wu, Thomas Brett Kirk, Dong Ma, Wei Xue. (2017) Biocompatible hyperbranched polyglycerol modified β-cyclodextrin derivatives for docetaxel delivery. Materials Science & Engineering C-Materials for Biological Applications, 71 (965). [PMID:27987795] [10.1016/j.msec.2016.11.005] |
37. Xiaoyan Zhou, Qianqian Zheng, Changyong Wang, Jiake Xu, Jian-Ping Wu, Thomas Brett Kirk, Dong Ma, Wei Xue. (2016) Star-Shaped Amphiphilic Hyperbranched Polyglycerol Conjugated with Dendritic Poly(l-lysine) for the Codelivery of Docetaxel and MMP-9 siRNA in Cancer Therapy. ACS Applied Materials & Interfaces, 8 (20): (12609–12619). [PMID:27153187] [10.1021/acsami.6b01611] |
38. De-Hong Yu, Ya-Rong Liu, Xin Luan, Hai-Jun Liu, Yun-Ge Gao, Hao Wu, Chao Fang, Hong-Zhuan Chen. (2015) IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance. BIOCONJUGATE CHEMISTRY, 26 (8): (1702–1712). [PMID:26076081] [10.1021/acs.bioconjchem.5b00283] |
39. Chang-Wei Li, Hua-Jin Dong, Cheng-Bin Cui. (2015) The Synthesis and Antitumor Activity of Twelve Galloyl Glucosides. MOLECULES, 20 (2): (2034-2060). [PMID:25633333] [10.3390/molecules20022034] |
40. Chao Yang, Lina Han, Fei Ma, Lin Zhou, Jiahong Zhou, Shaohua Wei, Guiqin Huang, Jian Shen, Fuyou Li. (2013) Synthesis of Calcium Phosphate Nanoparticle-Based Docetaxel Delivery System and its In Vitro Anticancer Activity. International Journal of Applied Ceramic Technology, 12 (2): (300-305). [PMID:] [10.1111/ijac.12159] |
1. Purba TS et al.. (2019) CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane-induced alopecia.. EMBO Mol Med, 11 (10): (e11031). [PMID:31512803] |
2. Zeng J et al.. (2018) PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.. Theranostics, 8 (109-123). [PMID:29290796] |
3. Kurniawan W et al.. (2020) The effects of docetaxel and/or captopril in expression of TGF-β1, MMP-1, CTGF, and PAI-1 as markers of anterior urethral stricture in an animal model.. Ther Adv Urol, 12 (1756287220927994). [PMID:35173811] |
4. Wei Pei, Yuqing Li, Yixian Wu, Yuan Wu, Ling Cai, Shaozhuo Wang, Shoulin Wang, Jin Chen. (2023) A Tumoricidal Lipoprotein Complex Electrostatically Stabilized on Mesoporous Silica as Nanotherapeutics and Nanoadjuvant for Potentiating Immunotherapy of Triple Negative Breast Cancer. ADVANCED FUNCTIONAL MATERIALS, (2308117). [PMID:19463981] [10.1002/adfm.202308117] |
5. Shuncheng Yao, Shaobo Wang, Minjia Zheng, Zhuo Wang, Zhirong Liu, Zhong Lin Wang, Linlin Li. (2023) Implantable, Biodegradable, and Wireless Triboelectric Devices for Cancer Therapy Through Disrupting Microtubule and Actins Dynamics. ADVANCED MATERIALS, (2303962). [PMID:37392034] [10.1002/adma.202303962] |
6. Zhuang Yu, Wang Yuxiao, Li Ning, Meng Haitao, Li Zhiyu, Luo Jianguang, Qiu Zhixia. (2023) Hydrolytic Metabolism of Withangulatin A Mediated by Serum Albumin Instead of Common Esterases in Plasma. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 48 (4): (363-376). [PMID:37344636] [10.1007/s13318-023-00834-8] |
7. Jiawei Li, Chunmei Fan, Zhongyang Lv, Ziying Sun, Jie Han, Maochun Wang, Huiming Jiang, Kuoyang Sun, Guihua Tan, Hu Guo, Anlong Liu, Heng Sun, Xingquan Xu, Rui Wu, Wenjin Yan, Qing Jiang, Shiro Ikegawa, Xiao Chen, Dongquan Shi. (2023) Microtubule stabilization targeting regenerative chondrocyte cluster for cartilage regeneration. Theranostics, 13 (10): ( 3480–3496). [PMID:37351173] [10.7150/thno.85077] |
8. Rengui Xu, Honglian Guo, Xiuli Chen, Jiarong Xu, Yusheng Gong, Peng Cao, Chunyu Wei, Fei Xiao, Di Wu, Wei Chen, Lin Wang, Zheng Wang. (2023) Smart hydrothermally responsive microneedle for topical tumor treatment. JOURNAL OF CONTROLLED RELEASE, 358 (566). [PMID:37182803] [10.1016/j.jconrel.2023.05.008] |
9. Qinhui Ren, Yufu Ma, Fuhua Wei, Lan Qin, Hongliang Chen, Zhao Liang, Siyuan Wang. (2023) Preparation of Zr-MOFs for the adsorption of doxycycline hydrochloride from wastewater. Green Processing and Synthesis, 12 (1): [PMID:] [10.1515/gps-2022-8127] |
10. Tan Hu, Yang Xu, Gang Xu. (2023) Dipeptide-polysaccharides hydrogels through co-assembly. FOOD CHEMISTRY, 422 (136272). [PMID:37141751] [10.1016/j.foodchem.2023.136272] |
11. Fang Fang, Shaohua Zhang, Chaofan Chen, Xueying Wang, Chuannan Luo, Qin Wei. (2023) A fluorescent nanoprobe based on N/S co-doped carbon dots coupled with molecularly imprinted polymers for the detection of curcumin. OPTICAL MATERIALS, 139 (113800). [PMID:] [10.1016/j.optmat.2023.113800] |
12. Zhen Yu, Xundou Li, Jinhong Duan, Xian-Da Yang. (2023) Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel. International Journal of Nanomedicine, [PMID:32982230] [10.2147/IJN.S267177] |
13. Tong Le, Zhou ZeYang, Wang Gang, Wu Chao. (2023) A self-microemulsion enhances oral absorption of docetaxel by inhibiting P-glycoprotein and CYP metabolism. Drug Delivery and Translational Research, 13 (4): (983-993). [PMID:36515864] [10.1007/s13346-022-01255-x] |
14. Li Huang, Huaqiang Fang, Teng Zhang, Binbin Hu, Shichen Liu, Fanzhen Lv, Zhaoxia Zeng, Huijie Liu, Weimin Zhou, Xiaolei Wang. (2023) Drug-loaded balloon with built-in NIR controlled tip-separable microneedles for long-effective arteriosclerosis treatment. Bioactive Materials, 23 (526). [PMID:36514389] [10.1016/j.bioactmat.2022.11.015] |
15. Ruifeng Wu, Zhiqiang Zhang, Baohua Wang, Ge Chen, Yaozhong Zhang, Haowen Deng, Zilong Tang, Junjie Mao, Lei Wang. (2022) Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles. Drug Design Development and Therapy, [PMID:32606595] [10.2147/DDDT.S246574] |
16. Dongsheng Fu, Jinhui You, Ruijie Guo, Jie Zhang, Qiang Li, Jing Wen, Huifang Wang, Hong Yan. (2022) Preparation of Nanostructured Graphene Oxide and Its Application in Drug Loading and Sustained Release. ChemistrySelect, 7 (30): (e202200670). [PMID:] [10.1002/slct.202200670] |
17. Hongming Liu, Qin Zhou, Yongfu Lian. (2022) Polymethyl(1–Butyric acidyl)silane–Assisted Dispersion and Density Gradient Ultracentrifugation Separation of Single–Walled Carbon Nanotubes. Nanomaterials, 12 (12): (2094). [PMID:35745430] [10.3390/nano12122094] |
18. Lingling Xu, Chuan Zhou, Fan Wang, Huiqin Liu, Guangyuan Dong, Siyi Zhang, Tao Liu. (2022) Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells. RSC Advances, 12 (28): (18004-18011). [PMID:35765336] [10.1039/D2RA02301F] |
19. Wei Pei, Ling Cai, Xing Gong, Li Zhang, Jiarong Zhang, Ping Zhu, Huijun Jiang, Chao Wang, Shoulin Wang, Jin Chen. (2022) Drug-loaded oleic-acid grafted mesoporous silica nanoparticles conjugated with α-lactalbumin resembling BAMLET-like anticancer agent with improved biocompatibility and therapeutic efficacy. Materials Today Bio, 15 (100272). [PMID:35607417] [10.1016/j.mtbio.2022.100272] |
20. Yingying Zhang, Hongxia Duan, Heming Zhao, Lingling Qi, Yanhong Liu, Zheao Zhang, Chao Liu, Liqing Chen, Mingji Jin, Youyan Guan, Zhonggao Gao, Wei Huang. (2022) Development and Evaluation of a PSMA-Targeted Nanosystem Co-Packaging Docetaxel and Androgen Receptor siRNA for Castration-Resistant Prostate Cancer Treatment. Pharmaceutics, 14 (5): (964). [PMID:35631549] [10.3390/pharmaceutics14050964] |
21. Jia Gao, Li Chen, Yongsheng Yan, Jian Lu, Wendong Xing, Jiangdong Dai, Minjia Meng, Yilin Wu. (2021) Dot-matrix-initiated molecularly imprinted nanocomposite membranes for selective recognition: a high-efficiency separation system with an anti-oil fouling layer. Environmental Science-Nano, 8 (10): (2932-2949). [PMID:] [10.1039/D1EN00296A] |
22. Yingying Chai, Yuefei Wang, Bingqi Li, Wei Qi, Rongxin Su, Zhimin He. (2021) Microfluidic Synthesis of Lignin/Chitosan Nanoparticles for the pH-Responsive Delivery of Anticancer Drugs. LANGMUIR, 37 (23): (7219–7226). [PMID:34078082] [10.1021/acs.langmuir.1c00778] |
23. Ruiqi Xu, Mengnan Zeng, Yuanyuan Wu, Shengchao Wang, Beibei Zhang, Jingke Zhang, Yuxuan Kan, Benke Li, Bing Cao, Xiaoke Zheng, Weisheng Feng. (2021) Acetone Extract of Cornus officinalis Leaves Exerts Anti-Melanoma Effects via Inhibiting STAT3 Signaling. OncoTargets and Therapy, 14 ( 3487–3501). [PMID:34093025] [10.2147/OTT.S308371] |
24. Wenjia Wang, Xiaoqin Zhang, Zhiqian Li, Dayi Pan, Hongyan Zhu, Zhongwei Gu, Jie Chen, Hu Zhang, Qiyong Gong, Kui Luo. (2021) Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy. CARBOHYDRATE POLYMERS, 267 (118160). [PMID:34119134] [10.1016/j.carbpol.2021.118160] |
25. Zhirong Zhu, Guiliang Tang, Jiajun Yan. (2020) MicroRNA‑122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2. Experimental and Therapeutic Medicine, 20 (6): (1-1). [PMID:33178345] [10.3892/etm.2020.9377] |
26. Hongyan Zhang, Shuang Dong, Sheng Zhang, Yufen Li, Ji Li, Yinghui Dai, Dongkai Wang. (2021) pH-responsive lipid polymer hybrid nanoparticles (LPHNs) based on poly (β-amino ester) as a promising candidate to resist breast cancers. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 61 (102102). [PMID:] [10.1016/j.jddst.2020.102102] |
27. Yuan He, Zhuyifan Ye, Xinyang Liu, Zhengjie Wei, Fen Qiu, Hai-Feng Li, Ying Zheng, Defang Ouyang. (2020) Can machine learning predict drug nanocrystals?. JOURNAL OF CONTROLLED RELEASE, 322 (274). [PMID:32234511] [10.1016/j.jconrel.2020.03.043] |
28. Tian'e Chen, Liangxing Tu, Ge Wang, Na Qi, Wei Wu, Wei Zhang, Jianfang Feng. (2020) Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 578 (119105). [PMID:32018019] [10.1016/j.ijpharm.2020.119105] |
29. Yao Yang, Zhengwei Huang, Jinyuan Li, Ziran Mo, Ying Huang, Cheng Ma, Wenhao Wang, Xin Pan, Chuanbin Wu. (2019) PLGA Porous Microspheres Dry Powders for Codelivery of Afatinib-Loaded Solid Lipid Nanoparticles and Paclitaxel: Novel Therapy for EGFR Tyrosine Kinase Inhibitors Resistant Nonsmall Cell Lung Cancer. Advanced Healthcare Materials, 8 (23): (1900965). [PMID:31664795] [10.1002/adhm.201900965] |
30. Jiafeng Gao, Kai Fan, Yipeng Jin, Linna Zhao, Qian Wang, Yinian Tang, Huihao Xu, Zhongjie Liu, Shuaiyu Wang, Jiahao Lin, Degui Lin. (2019) PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 140 (105070). [PMID:31518679] [10.1016/j.ejps.2019.105070] |
31. Wei Fu, Zhiming Hong, Xujun You, Jing Din, Baishu Chen, Beibei Zhao, Gengyan Yuan, Qixin Li. (2019) Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer. BIOMEDICINE & PHARMACOTHERAPY, 118 (109374). [PMID:31545228] [10.1016/j.biopha.2019.109374] |
32. Tao Liu, Jingzhen Li, Xidong Wu, Siyi Zhang, Zhongming Lu, Guanxue Li, Junzheng Li, Shaohua Chen. (2019) Transferrin-targeting redox hyperbranched poly(amido amine)-functionalized graphene oxide for sensitized chemotherapy combined with gene therapy to nasopharyngeal carcinoma. DRUG DELIVERY, 26 (1): (744-755). [PMID:31340676] [10.1080/10717544.2019.1642421] |
33. Ting Zhao, Shiwei Qin, linna Peng, Pan Li, Tao Feng, Jingyuan Wan, Pei Yuan, Liangke Zhang. (2019) Novel hyaluronic acid-modified temperature-sensitive nanoparticles for synergistic chemo-photothermal therapy. CARBOHYDRATE POLYMERS, 214 (221). [PMID:30925992] [10.1016/j.carbpol.2019.03.043] |
34. Ruoning Wang, Mengmeng Yang, Guoyuan Li, Xin Wang, Zhenhai Zhang, Hongzhi Qiao, Jun Chen, Zhipeng Chen, Xiaobin Cui, Junsong Li. (2019) Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity. COLLOIDS AND SURFACES B-BIOINTERFACES, 174 (270). [PMID:30469048] [10.1016/j.colsurfb.2018.11.029] |
35. Lei Xu, Shuo Wu, Xiaoqiu Zhou. (2018) Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma. JOURNAL OF BIOMATERIALS APPLICATIONS, [PMID:29699442] [10.1177/0885328218772721] |
36. Ling-Yuan Guo, Shu-Zhen Yan, Qiang Li, Qiao Xu, Xi Lin, Shan-Shan Qi, Shu-Qin Yu, Shuang-Lin Chen. (2017) Poly(lactic-co-glycolic) acid nanoparticles improve oral bioavailability of hypocrellin A in rat. RSC Advances, 7 (67): (42073-42082). [PMID:] [10.1039/C7RA04748G] |
37. Lin Yu, Xiaofeng Wu, Min Chen, Huarong Huang, Yan He, Huaqian Wang, Dongli Li, Zhiyun Du, Kun Zhang, Susan Goodin, Xi Zheng. (2017) The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer. International Journal of Medical Sciences, 14 (4): ( 356–366). [PMID:28553168] [10.7150/ijms.18382] |
38. Enhui Zhang, Ronge Xing, Song Liu, Kecheng Li, Yukun Qin, Huahua Yu, Pengcheng Li. (2017) Comparison in docetaxel-loaded nanoparticles based on three different carboxymethyl chitosans. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 101 (1012). [PMID:28389400] [10.1016/j.ijbiomac.2017.03.195] |
39. Zejun Xu, Yi Zhang, Qian Hu, Qiao Tang, Jiake Xu, Jianping Wu, Thomas Brett Kirk, Dong Ma, Wei Xue. (2017) Biocompatible hyperbranched polyglycerol modified β-cyclodextrin derivatives for docetaxel delivery. Materials Science & Engineering C-Materials for Biological Applications, 71 (965). [PMID:27987795] [10.1016/j.msec.2016.11.005] |
40. Xiaoyan Zhou, Qianqian Zheng, Changyong Wang, Jiake Xu, Jian-Ping Wu, Thomas Brett Kirk, Dong Ma, Wei Xue. (2016) Star-Shaped Amphiphilic Hyperbranched Polyglycerol Conjugated with Dendritic Poly(l-lysine) for the Codelivery of Docetaxel and MMP-9 siRNA in Cancer Therapy. ACS Applied Materials & Interfaces, 8 (20): (12609–12619). [PMID:27153187] [10.1021/acsami.6b01611] |
41. De-Hong Yu, Ya-Rong Liu, Xin Luan, Hai-Jun Liu, Yun-Ge Gao, Hao Wu, Chao Fang, Hong-Zhuan Chen. (2015) IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance. BIOCONJUGATE CHEMISTRY, 26 (8): (1702–1712). [PMID:26076081] [10.1021/acs.bioconjchem.5b00283] |
42. Chang-Wei Li, Hua-Jin Dong, Cheng-Bin Cui. (2015) The Synthesis and Antitumor Activity of Twelve Galloyl Glucosides. MOLECULES, 20 (2): (2034-2060). [PMID:25633333] [10.3390/molecules20022034] |
43. Chao Yang, Lina Han, Fei Ma, Lin Zhou, Jiahong Zhou, Shaohua Wei, Guiqin Huang, Jian Shen, Fuyou Li. (2013) Synthesis of Calcium Phosphate Nanoparticle-Based Docetaxel Delivery System and its In Vitro Anticancer Activity. International Journal of Applied Ceramic Technology, 12 (2): (300-305). [PMID:] [10.1111/ijac.12159] |